VISTITAN

Sandoz Canada, Inc.🇨🇦 Health Canada

Approval Id: 9cca110e7815f9dc
Drug Approval Canada Name: VISTITAN
Product Name: VISTITAN
Status: Marketed
Status Date: 2016-05-13
Original Market Date: 2016-05-13
Din: 02429063
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Ophthalmic
Schedule: Prescription
Ahfs: 52:40.28
Atc Original: S01EE03 BIMATOPROST
Atc Name: s 01 ee 03
Aig Number: 0147303001
Company Name: Sandoz Canada, Inc.
Company Address: 4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path: /organization/sandoz-canada-inc

BIMATOPROST

0.03 % / W/V

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

9cca110e7815f9dc

Type

Standard